Financials

  • Market Capitalization 941.93 M
  • Employee 489
  • Founded 2007
  • CEO Mike Raab
  • Website www.ardelyx.com
  • Headquarter Delaware, United States
  • FIGI BBG001WH4DQ3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-22.17
Rapporto prezzo/fatturato
2.76

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2489
DSGN
Design Therapeutics, Inc. - Common Stock
15.09 USD-0.13%-2.27%+25.33%+173.37%944.36 M USD
2494
ANNX
Annexon, Inc. - common stock
4.94 USD-0.60%-3.70%-2.37%+139.81%936.52 M USD
2507
OLMA
Olema Pharmaceuticals, Inc. - Common Stock
10.43 USD+1.56%-1.60%-8.75%+27.35%912.60 M USD
2514
IVA
Inventiva S.A. - American Depository Shares
4.68 USD-0.64%-0.21%+6.61%-14.75%904.35 M USD

Notizie